What should psychedelic science take - and not take - from other disciplines? Join us in celebrating the book launch of The Oxford Handbook of Psychedelic, Religious, Spiritual, and Mystical Experiences on Wed, Aug 5th from 10am-2pm ET. Attend in-person in Washington DC or virtually on Zoom.

Dr. David Yaden shares insights and safety considerations for Oregon’s psilocybin services program with the Oregon Capital Chronicle: oregoncapitalchronicle.com/2026/06/30/g...

Growing scope of Oregon psilocybin program raises safety concerns, study says • Oregon Capital Chronicle

Some of the top reasons people use Oregon's program include health and wellness, changes in perspective and "expanded concsiousness."

oregoncapitalchronicle.com

Do you live with chronic low back pain and depression? You’re not alone. Our research team at Johns Hopkins is studying whether psilocybin may help with pain and mood. If you’d like to learn more or see if you qualify, visit the link below. hopkinspsychedelic.org/backpain

Can Psychedelics Treat Addiction? Dr. Albert Garcia-Romeu was interviewed by Dr. Jonathan Avery on Thriving with Addiction podcast, discussing his research on the effects of psychedelics on addiction:

Can Psychedelics Treat Addiction? with Dr. Albert Garcia-Romeu

Podcast Episode · Thriving with Addiction with Dr. Jonathan Avery · July 14 · 40m · Video

podcasts.apple.com

The CPCR is seeking a full-time Clinical Program Coordinator to join our team and support clinical trials and studies in the field of psychedelic science. Learn more and apply here: hiring.jhu.edu/careers/job/...

Last month, CPCR Postdoctoral Research Fellow, David S. Rosen @docdurdur.bsky.social, presented neural and behavioral results from our music and psilocybin, non-drug, immersive listening pilot study at the Society for the Neuroscience of Creativity’s 2026 Conference in Philadelphia.

We are seeking healthy individuals to take part in a Johns Hopkins research study. The study will look at the effects of psilocybin, a psychedelic drug, with pindolol (a medication that blocks a serotonin receptor).

Congratulations to Dr. Praachi Tiwari on her promotion to faculty at the Johns Hopkins University School of Medicine!

Congratulations to Dr. Gideon Naudé on his promotion to Research Associate in the School of Medicine!

In a recent paper, CPCR researchers analyzed the first full year of data from the Oregon Health Authority, examining how Oregon’s policy has balanced safety and access to psychedelics outside of clinical settings. See the full paper here: www.sciencedirect.com/science/arti...

Researchers at Johns Hopkins University are investigating psilocybin, a psychedelic substance found in some species of mushrooms, to see if it can help people with Amyotrophic Lateral Sclerosis (ALS) overcome depression.

CPCR Associate Professor Dr. David Yaden was interviewed in an article with the Atlantic, providing insights on the safety, efficacy, and opportunities for psychedelic studies: www.theatlantic.com/health/2026/...

The New Science of Psychedelic Drugs

University researchers are looking for ways to engineer better mind-altering therapeutic experiences

theatlantic.com

Join us Wednesday, June 24, 2026 at 4:30pm ET for the Psychedelic Archives Project guest speaker series, featuring Dr. Kurt Stocker, presenting “The Many Roads to Nonordinary Consciousness”. Join on this Zoom link: jhubluejays.zoom.us/j/92622903856

Congratulations to Dr. Ceyda Sayalı on receiving the prestigious IBRO Rising Stars Award! 🧠 Her lab at Johns Hopkins combines brain stimulation, fMRI, and psychedelics like psilocybin to map how the brain rewires itself — work that could reshape treatment for depression and substance use disorders.

The CPCR participated in Health Research Day 2026 at Canton Waterfront Park this past weekend. We had a great time connecting with community members! Thank you to Hopkins ICTR for organizing this event and bridging the gap between health research and the Baltimore community.

CPCR Associate Director Dr. Albert Garcia-Romeu weighed in on a recent case report of psilocybin administration for an individual with suspected Alzheimer's Disease, noting some important concerns about the report. themicrodose.substack.com/p/an-amanita...

An Amanita mushroom poisoning outbreak in California; A case report testing psilocybin for advanced Alzheimer’s disease

Plus: Scientists assess risk of psychedelic-induced mania; and the close of this season’s psychedelic legislation push

themicrodose.substack.com

Want to listen to music with psychedelics? Researchers at Johns Hopkins University are seeking healthy individuals ages 21-75 to participate in a research study evaluating the role of music during psychedelic experiences. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...

Dr. Sandeep Nayak presented findings from our clinical trial of psilocybin for PTSD at the Interdisciplinary Conference on Psychedelic Research (ICPR) 2026 in the Netherlands. Stay tuned for full results published soon!

Interested in experiencing psychedelics under professional supervision? We are seeking healthy adults between the ages 21-65 to participate in a new clinical trial looking at the effects of psilocybin and its interaction with other medications. Apply at jhmi.co1.qualtrics.com/jfe/form/SV_...

CPCR Assistant Professor, Dr. Brandon Weiss, interviews with CNBC regarding the executive order on accelerated psychedelic research. Weiss cautions that there are different risks associated with each psychedelic compound:

JHU PhD student Katherine Cheung and PhD Candidate Caleigh Propes, with CPCR Associate Professor Dr. David Yaden, evaluated comparison sets on the price of Oregon’s psilocybin services.

Drs. Fred Barrett and David Yaden have received a 2026 Johns Hopkins Nexus Award alongside fellow JHU scientists, educators, bioethicists, and economists to advance critical conversations around the future of psychedelic policy. hub.jhu.edu/2026/05/29/j...

Johns Hopkins announces funding for Washington, D.C.-based projects and research

The Nexus Awards Program supports a diverse range of programming, research, and teaching activities at the Hopkins Bloomberg Center

hub.jhu.edu

Join us tomorrow, Wednesday May 27, for the Psychedelic Archives Project Guest Speaker Series! 🎤Dr. Timo Schmidt ( @Titoschmi ) 🗓 May 25, 2026 | ⏰ 4:30 PM EDT 🎟 Free to attend — sign up at the link below and in our bio!👇 jhubluejays.zoom.us/j/92622903856

Congratulations to Kristy Arthur on an outstanding showing at the Collaborative Perspectives on Addiction Annual Meeting!

This Memorial Day, we honor those who gave everything in service to this country and we hold space for those still carrying invisible wounds.

Check out this thoughtful interview with Dr. Bit Yaden and Josh Hardman at Psychedelic Alpha, discussing a collaborative educational project between Johns Hopkins, NYU, Penn, and Yale. psychedelicalpha.com/news/bit-yad...

Bit Yaden on Preparing the Next Generation of Psychiatrists for a Psychedelic Future

We speak to Dr. Bit Yaden about a multi-instituion project to teach psychedelic medicine to resident psychiatrists.

psychedelicalpha.com

CPCR Medical Director, Dr. Sandeep Nayak, interviews with Forbes on the psychedelic compound, methylone, being explored in FDA-approved research for post-traumatic stress disorder: www.forbes.com/health/mind/...

What Is Methylone? One Psychedelic Drug Getting FDA Fast-Track Status

forbes.com

CPCR Medical Director, Dr. Sandeep Nayak, will be speaking at the Interdisciplinary Conference on Psychedelic Research in the Netherlands on June 4-6!

Rodrigo Guerra, biomedical engineering PhD candidate with the CPCR, was recognized as 2026 Graduate Student Employee of the Year in April! This award is reserved for those who go above and beyond in their roles among thousands of undergrad and graduate student employees at Johns Hopkins University.

We are seeking individuals to participate in a research study on the effects of psychedelics on addictive behaviors including problems with gambling, video gaming, internet/social media, pornography and other sexual behaviors, and shopping and buying behaviors. hopkinspsychedelic.org/addictionsur...